Results 101 to 110 of about 136,968,345 (168)

Glioblastoma Stem Cells and Withaferin A, A Review [PDF]

open access: yesBiomedical Journal of Scientific & Technical Research, 2019
Glioblastoma multiforme is characterized by tumor cell heterogeneity, and by recurrent invasive tumors following conventional radiation, cytotoxic drugs, and limited ablative surgery [1-5]...
openaire   +1 more source

Withaferin A is a Leptin Sensitizer with Strong Anti-Diabetic Properties in Mice

open access: yes, 2018
The increasing global prevalence of obesity and its associated disorders point to an urgent need for the development of novel and effective therapeutic strategies that induce healthy weight loss.
Lee, Jaemin   +7 more
core   +1 more source

Withaferin A decreases glycolytic reprogramming in breast cancer

open access: yesScientific Reports
Reprogrammed glucose metabolism is considered as the hallmark of cancer with therapeutic implications. Phytocompounds have potential to inhibit cancer metabolism. Here, we tested the ability of Withaferin A (WA), a withanolide derived from Withania somnifera, in modulating cancer metabolism.
Asifa Khan   +8 more
openaire   +3 more sources

pH-Responsive Gold Nanoparticle/PVP Nanoconjugate for Targeted Delivery and Enhanced Anticancer Activity of Withaferin A

open access: yes
The development of advanced high-capacity nanoparticle-based drug loading, precise targeting, low toxicity, and excellent biocompatibility is critical for improving cancer therapeutics.
Paulraj Arunkumar   +2 more
core   +1 more source

Mortalin, a target of withanone and withaferin A.

open access: yes, 2013
Docking of withanone (Wi-N) (A) and withaferin A (Wi-A) (B) in the “latch region” of mortalin (PDB-id: 3N8E). (C) Quantitative analysis of mortalin in human cancer (U2OS) cells treated with various doses of Wi-N and Wi-A. (D) Imaging of mortalin in human
M. Uthayakumar (308967)   +9 more
core   +1 more source

NRF2, a target of withanone and withaferin A.

open access: yes, 2013
Docking of withanone (Wi-N) (A) and withaferin A (Wi-A) (B) with Nrf-2 (PDB-id: 2FLU), and Western blot analysis of Nrf2 in U2OS cells treated with Wi-A and Wi-N (C). (D) Detection of Nrf2 in the nuclear and cytosolic fractions of cells treated with Wi-A
M. Uthayakumar (308967)   +9 more
core   +1 more source

Withaferin A Inhibits Nuclear Factor-κB-Dependent Pro-Inflammatory and Stress Response Pathways in the Astrocytes

open access: yesNeural Plasticity, 2015
Several lines of evidence suggest that astrocytes play a key role in modulating the immune responses of the central nervous system (CNS) to infections, injuries, or pathologies. Yet, their contribution to these processes remains mostly elusive. Astroglia
Francesca Martorana   +3 more
doaj   +1 more source

Optimization of Carbon Source for Hairy Root Growth and Withaferin A and Withanone Production in

open access: yesNatural Product Communications, 2012
This study optimized carbon sources in half MS liquid medium for maximum biomass accumulation and withanolides production in hairy root culture of Withania somnifera .
Ganeshan Sivanandhan   +7 more
doaj   +1 more source

Implications of Withaferin A in neurological disorders

open access: yesNeural Regeneration Research, 2020
Natasha Ram   +3 more
openaire   +3 more sources

Withaferin-A inhibits colorectal cancer growth and metastasis by targeting the HSP90/HIF-1α/EMT axis

open access: yes
Introduction Withaferin-A (WA) derived from natural products can inhibit the growth and metastasis of colorectal cancer (CRC) in vitro and in vivo. Transcriptome sequencing showed that WA inhibited the epithelial-mesenchymal transition pathway (EMT ...
Chun-ming Wang   +6 more
core   +1 more source

Home - About - Disclaimer - Privacy